Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.
Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, Beauloye C, Bruno RM, Chenu P, de Leeuw P, De Backer T, Delmotte P, Dika Z, Gordin D, Heuten H, Iwashima Y, Krzesinski JM, Kroon AA, Mazzolai L, Poch E, Sarafidis P, Seinturier C, Spiering W, Toubiana L, Van der Niepen P, van Twist D, Visonà A, Wautrecht JC, Witowicz H, Xu J, Prejbisz A, Januszewicz A, Azizi M, Persu A; European/International FMD Registry and Initiative (FEIRI), and the Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH). Pappaccogli M, et al. Among authors: visona a. Cardiovasc Res. 2021 Feb 22;117(3):950-959. doi: 10.1093/cvr/cvaa102. Cardiovasc Res. 2021. PMID: 32282921 Free article.
Vascular risk assessment and management.
Bigolin P, Zalunardo B, Mazzolai L, Belch J, Visonà A. Bigolin P, et al. Among authors: visona a. Vasa. 2022 Nov;51(6):351-356. doi: 10.1024/0301-1526/a001026. Epub 2022 Sep 6. Vasa. 2022. PMID: 36065794
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.
Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, Roztocil K, Colgan MP, Vasic D, Gottsäter A, Amann-Vesti B, Chraim A, Poredoš P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman Z. Belch J, et al. Among authors: visona a. Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12. Vasa. 2017. PMID: 28895508 Free article. Review.
UEMS Training Requirements for Angiology/Vascular Medicine: European Standards of Postgraduate Medical Specialist Training (2022 Updated Version).
Wautrecht JC, Olinic DM, Catalano M, Baines C, Belch J, Blinc A, Buschmann I, Celovska D, Colgan MP, Dimakakos E, Heiss C, Kolossvary E, Kozak M, Kroon B, Mazzolai L, Marakomichelakis G, Pecsvarady Z, Pias Canedo MA, Quere I, Roztocil K, Schernthaner GH, Sieron A, Spaak J, Sprynger M, Stanek A, Staub D, Vasic D, Visona A, Willfort-Ehringer A; Endorsed by VAS and ESVM. Wautrecht JC, et al. Among authors: visona a. Int Angiol. 2022 Jun;41(3):258-274. doi: 10.23736/S0392-9590.22.04893-3. Epub 2022 Apr 4. Int Angiol. 2022. PMID: 35373943 Free article. No abstract available.
Post-thrombotic syndrome.
Visonà A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P; European Society of Vascular Medicine (ESVM). Visonà A, et al. Vasa. 2021 Sep;50(5):331-340. doi: 10.1024/0301-1526/a000946. Epub 2021 Mar 15. Vasa. 2021. PMID: 33720757
ESVM integrated care pathways - a call for action.
Visonà A, Pesavento R, Mazzolai L, Cimminiello C, Pécsvárady Z, Olinic D, Johansson E. Visonà A, et al. Vasa. 2019 Mar;48(2):113-114. doi: 10.1024/0301-1526/a000755. Vasa. 2019. PMID: 30821213 No abstract available.
Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry.
Siniscalchi C, Suriñach JM, Visonà A, Fernández-Reyes JL, Gómez-Cuervo C, Verhamme P, Marchena PJ, Farge-Bancel D, Moisés J, Monreal M; and the RIETE Investigators. Siniscalchi C, et al. Among authors: visona a. TH Open. 2020 Sep 17;4(3):e236-e244. doi: 10.1055/s-0040-1716734. eCollection 2020 Jul. TH Open. 2020. PMID: 32964178 Free PMC article.
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
Dimakakos E, Gomatou G, Catalano M, Olinic DM, Spyropoulos AC, Falanga A, Maraveyas A, Liew A, Schulman S, Belch J, Gerotziafas G, Marschang P, Cosmi B, Spaak J, Syrigos K; CANCER-COVID-19 THROMBOSIS COLLABORATIVE GROUP, endorsed by VAS-European Independent Foundation in Angiology/Vascular Medicine, UEMS Vascular Medicine/Angiology and European Society of Vascular Medicine, and supported by the Balkan Working Group for Prevention and Treatment of Venous Thromboembolism and Hellenic Association of Lung Cancer. Dimakakos E, et al. Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815. Anticancer Res. 2022. PMID: 35790272 Review.
248 results